Scrambler Therapy in the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy
A Pilot Randomized Sham-Controlled Trial of MC5-A Calmare Therapy (Scrambler Therapy) in the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy (CIPN)
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Listed as NCT02111174, this NA trial focuses on Neuropathy and remains completed. Sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, it has been updated 8 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Sep 2018 — Jan 2021 [monthly]
Completed NA
-
Jun 2018 — Sep 2018 [monthly]
Completed NA
▶ Show 3 earlier versions
-
May 2017 — Jun 2018 [monthly]
Completed NA
Status: Recruiting → Completed · Phase: PHASE2 → NA
-
Feb 2017 — May 2017 [monthly]
Recruiting PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE2
First recorded
Mar 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
For direct contact, visit the study record on ClinicalTrials.gov .